Skip to content

Periodontal Disease and Salivary Mitofusin Levels

Evaluation of the Roles of Salivary Mitofusin-1 and Mitofusin-2 Levels in Periodontal Disease

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06510608
Enrollment
81
Registered
2024-07-19
Start date
2024-07-25
Completion date
2024-09-25
Last updated
2024-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingivitis, Periodontal Diseases, Periodontitis

Brief summary

The aim of this observational study is to find out whether there is a level difference in salivary mitofusin-1 and mitofusin-2 levels due to changes in periodontal status. The main question it aims to answer is: * Do salivary mitofusin-1 and mitofusin-2 levels of periodontitis patients differ from healthy patients? * Could salivary mitofusin-1 and mitofusin-2 levels be biomarkers for periodontal disease? Biochemical analysis will be performed on saliva samples taken at once from gingivitis or periodontitis patients and healthy individuals who apply to the periodontology clinic, at the initial stage of the treatment. There is no ongoing monitoring or second sampling.

Interventions

DIAGNOSTIC_TESTBiochemical analysis of saliva sample

It is the examination of saliva samples taken with biochemical methods. In this way, the substances in its content and the concentration of cytokines are analyzed.

Sponsors

Erzincan University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Being between the ages of 18 and 65. * Willing to participate in the study and provide a saliva sample. * Having a healthy periodontal condition, gingivitis, or periodontitis (Stage 3-4, Grade C). * Having fasted from any food or drink (except water) for the past 2 hours prior to providing the saliva sample. * Having refrained from brushing teeth or using mouthwash in the past 2 hours prior to providing the saliva sample. * Not having any systemic diseases. * Not currently taking any medications regularly.

Exclusion criteria

* Having used antibiotics within the last 6 months. * Having received periodontal treatment within the last 6 months. * Having fewer than 20 teeth (excluding third molars). * Having any systemic diseases. * Not smoking or having quit at least 5 years ago.

Design outcomes

Primary

MeasureTime frameDescription
Mitofusin-1 concentrationUp to four weeks from start of workMitofusin-1 concentration in saliva, determined as a result of biochemical analysis
Mitofusin-2 concentrationUp to four weeks from start of workMitofusin-2 concentration in saliva, determined as a result of biochemical analysis
IL-1B concentrationUp to four weeks from start of workIL-1B concentration in saliva, determined as a result of biochemical analysis

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026